Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
European Journal of Medicinal Chemistry
|
December 11, 2020
Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective
Sharyu Kesharwani, Sandeep Sundriyal
RSC Advances
|
September 2, 2024
Design and synthesis of non-hydroxamate lipophilic inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): <i>in silico</i>, <i>in vitro</i> and antibacterial studies
Sharyu Kesharwani, Eeba, Mukesh Tandi, et al.
Therapeutic Delivery
|
June 3, 2025
Quercetin-Eudragit® polymer complexes with enhanced loading, solubility, stability, and site-specific targeting
Siddharth S Kesharwani, Casey L Sayre, Sharyu Kesharwani, et al.
Molecular Biology Reports
|
January 24, 2025
A review of the current status of biological effects of plant-derived therapeutics in breast cancer
Shantanu Pachal, Hitesh Kumar, Rupshee Jain, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 29, 2022
Identification of a new and diverse set of Mycobacterium tuberculosis uracil-DNA glycosylase (MtUng) inhibitors using structure-based virtual screening: Experimental validation and molecular dynamics studies
Prateek Raj, Karthik Selvam, Koyel Roy, et al.
European Journal of Medicinal Chemistry
|
July 3, 2023
Crystal structures of non-uracil ring fragments in complex with Mycobacterium tuberculosis uracil DNA glycosylase (MtUng) as a starting point for novel inhibitor design: A case study with the barbituric acid fragment
Sharyu Kesharwani, Prateek Raj, Anju Paul, et al.
Therapeutic Delivery
|
September 25, 2024
Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer
Boya Manasa Sai, Yirivinti Hayagreeva Dinakar, Hitesh Kumar, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
European Journal of Medicinal Chemistry
|
December 11, 2020
Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective
Sharyu Kesharwani, Sandeep Sundriyal
RSC Advances
|
September 2, 2024
Design and synthesis of non-hydroxamate lipophilic inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): <i>in silico</i>, <i>in vitro</i> and antibacterial studies
Sharyu Kesharwani, Eeba, Mukesh Tandi, et al.
Therapeutic Delivery
|
June 3, 2025
Quercetin-Eudragit® polymer complexes with enhanced loading, solubility, stability, and site-specific targeting
Siddharth S Kesharwani, Casey L Sayre, Sharyu Kesharwani, et al.
Molecular Biology Reports
|
January 24, 2025
A review of the current status of biological effects of plant-derived therapeutics in breast cancer
Shantanu Pachal, Hitesh Kumar, Rupshee Jain, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 29, 2022
Identification of a new and diverse set of Mycobacterium tuberculosis uracil-DNA glycosylase (MtUng) inhibitors using structure-based virtual screening: Experimental validation and molecular dynamics studies
Prateek Raj, Karthik Selvam, Koyel Roy, et al.
European Journal of Medicinal Chemistry
|
July 3, 2023
Crystal structures of non-uracil ring fragments in complex with Mycobacterium tuberculosis uracil DNA glycosylase (MtUng) as a starting point for novel inhibitor design: A case study with the barbituric acid fragment
Sharyu Kesharwani, Prateek Raj, Anju Paul, et al.
Therapeutic Delivery
|
September 25, 2024
Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer
Boya Manasa Sai, Yirivinti Hayagreeva Dinakar, Hitesh Kumar, et al.
Page
of 1